AUCTORES
Globalize your Research
Chat with us
Review | DOI: https://doi.org/10.31579/2693-4779/081
1 Department of environmental health engineering, School of public health Iran University of medical sciences, Tehran, Iran.
2 Anatomical Sciences Research Center, Kashan University of Medical Sciences, Kashan, Iran.
3 Department of Medical Physics and Radiology, Faculty of Paramedicine, Kashan University of Medical Sciences, Kashan, Iran.
4 Key Laboratory of Magnetic Resonance in Biological Systems, State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences-Wuhan National Laboratory for Optoelectronics, 430071 Wuhan, P.R. China.
*Corresponding Author: Mojtaba Ehsanifar. Department of environmental health engineering, School of public health Iran University of medical sciences, Tehran, Iran.
Citation: M Ehsanifar, M Rafati, J Wang. (2022). Neurological complications related to COVID-19 infections following exposure to airborne aerosol particles. Clinical Research and Clinical Trials. 5(3); DOI: 10.31579/2693-4779/081
Copyright: © 2022 Mojtaba Ehsanifar, This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 23 December 2021 | Accepted: 11 January 2022 | Published: 20 February 2022
Keywords: covid-19 infections; aerosol transmission; airborne aerosol particles; neurological complications; air pollution exposure
Some of the recent researches show that air pollutants such as particulate matter (PM), including fine particles (PM<2.5μm, PM2.5) and very fine particles (PM <0.1μm, PM 0.1) can reach the brain and affect CNS health. Neurological complications with Coronavirus Disease 2019 (COVID-19) have been observed. The aim of this review the relationship between air pollutants exposure and COVID-19 was focused on the role of airborne aerosol particles in the prevalence of the disease, as well as the neurological effects of COVID-19. It is not yet clear how the virus is transmitted from one sick person to another and why it is so transmissible. Viruses can be probably transmitted through speech and exhalation aerosols. Findings show that SARS-CoV-2 aerosol transmission is possible. Spike (S) proteins of SARS‑CoV‑2 determine tissue tropism using an angiotensin-converting enzyme receptor type2 (ACE-2) to bind to the cells. ACE-2 receptor is found in the tissues of the nervous system. Neurological disorders that occur with COVID-19 can have many pathophysiological backgrounds. Some are the result of a direct viral attack on tissues of the nervous system, others appear to be an autoimmune process post-viral, and still others appear to be the result of systemic and metabolic complications associated with critical illness.
The mechanisms by which air pollutants exposure, such as ultrafine particulate matters (UFPs; <100>.
In parallel, exposure to UFPs could significantly exacerbate inflammation by cellular proliferation and reorganization of the extracellular matrix [6], as well as weakening the pulmonary immune response [7]. This mechanism has been described by several toxicological studies [7, 8] and a lot of epidemiological evidence corroborates the role of exposure to chronic and acute air pollutants in the admission of respiratory hospitals, such as exacerbation of asthma [9] or chronic obstructive pulmonary disease [10].
Furthermore, several studies reported that air pollution exposure exacerbates the intensity of various respiratory diseases [11], for example influenza infection [12] and severe acute respiratory syndrome (SARS) or another coronavirus [13]. One study in the US indicates that exposure to PM2.5 and ozone was dangerous and increased the risk of SARS among older adults [14]. Based on this presupposition, it is possible that the air pollution exposure will alter the intensity of the COVID-19 symptoms or help explain the differential-spatial patterns of disease prevalence. Recent surveys have reported that people with severe COVID-19 may already have the respiratory disease [15-22]. Recent studies on viral respiratory disease (such as influenza) have shown that a viable virus can be emitted from infected peoples by speaking even breathing, without sneezing or coughing [23, 24]. Normal and ordinary speech converts significant amounts of respiratory particles into airborne aerosols. Experimental research has shown that vocalization emits up more aerosols than breathing [25], also, a recent study indicated the louder one speech, the more aerosols are produced [26]. COVID-19 is a severe respiratory infection, and recent studies clearly identified the SARS-CoV-2 presence in a tract of the respiratory system [27]. Therefore, particles derived from breath and speech may contain viruses. These particles may be due in part to the mechanism of "liquid film bursting" in alveoli in the pulmonary, and or through the vibration of the vocal cords during a speech [28]. The findings suggest that particles and aerosols in the air reach the brain and affect CNS health, with changes in the blood-brain barrier (BBB) or leakage and transmission along the olfactory nerve to the olfactory bulb (OB) and active Microglia are the main components [29, 30].
The relationship between air pollution exposure and COVID-19
Based on the previous studies, air pollutants exposure is closely related to respiratory infection due to other microorganisms [8, 11]. Also, it was shown that exposure to a high concentration of PM2.5 was associated with more acute lower respiratory infections [42]. A significant association between exposure to urban air PM and hospitalizations due to respiratory disease was reported using a model of distributed lag nonlinear [43]. In Thailand, time series analysis performed found that PM10, SO2, CO, O3 and NO2 were significantly related to an increased risk of admission to respiratory hospitals [46]. Another review found that exposure to NO2, SO2, and CO could increase the risk of respiratory diseases and was harmful to health [47]. Another study showed that there was a statistically significant link between exposure to a high level of air pollutants such as PM10, PM2.5, NO2, O3, CO, and COVID-19 infection [22, 33].
The COVID-19 is caused by SARS-CoV-2 [31-33], and it was first observed in December 2019 [34, 35]. In the following months, it rapidly spreads to all of China and gradually became a pandemic public health problem in the whole world [32, 36, 37]. Various studies have demonstrated that the risk of COVID-19 infection could increase following human-to-human contacts [36, 38, 39]. Thus, the mobility of the population has a remarkable effect on the COVID- 19 pandemic [40]. Previous findings have shown that exposure to urban air pollutants by carrying microorganisms is a risk factor for respiratory infections to make the pathogens invasive to the humans and affect the body's immunity to more expose people to pathogens [41-44]. Because COVID-19 is a severe respiratory disease and the SARS-CoV-2 can survive for hours in an aerosol. The impact of exposure to air pollution needed a careful survey [45], thus, the investigation of the effect the air pollution exposure on the COVID-19 infection is very interesting.
The concentration of PM2.5 as the main stem of viral susceptibility
Chronic exposure to air pollutants such as PM2.5, SO2, and NO2causes reduce lung function, respiratory disease, and cardiovascular disease [48-50]. In addition to causing a persistent inflammatory reaction, air pollutants have been shown to increase the risk of viruses targeting the respiratory tract, even in relatively young people [16, 17]. PM2.5 penetrates into peripheral lung air spaces [51] and can through interaction with the renin-angiotensin system (RAS) facilitate the viral infection. The pulmonary RAS include the two axes involved in the local inflammatory responses with the opposite functions [52]: the ACE /AngII /AT1R axis that is involved in the release of proinflammatory cytokines (TNF-a and IL-6). The ACE-2/Ang1-7/Mas axis that culminates in the Mas activation concludes that affects STAT3 and ERK and produces an anti-inflammatory effect. The angiotensin-converting enzyme2 (ACE2) protects against the RAS induced damage through two processes: 1) degradation of AngI and AngII to limit the substrate availability in adverse the receptor axis of ACE /AngII /AT1; 2) production of Ang1-7 to increase the capability of the substrate in ACE-2 /Ang1-7 /Mas receiver axis [52]. The ACE-2 knockout mice after the PM2.5 exposure are more prone to lung damage and reduced pulmonary repair compared to controls. This indicates an important role for the ACE-2 in protecting the lungs against air pollutants [53]. Chronic exposure to PM2.5 leads to upregulation of the pulmonary ACE expression and activity in mice that can be the protective response to the chronic harmful injury [53, 54]. Also, despite having normal function and structure of the lung, ACE-2 knockout mice compared with the control mice of wild-type, showed very intensive pathology of the acute respiratory distress syndrome (ARDS) [53, 55]. Coronavirus protein's spike facilitates the viral entry into the target cells by engaging the ACE-2 receptors [56]. ACE-2 is, predominantly expressed at the level of the alveolar, and explains viral tropism for the lower airways. In fact, by the interaction between the S1 subunit receptor-binding domain (RBD) in viral spike glycoproteins with ecto ACE-2 domain, binding and entry are facilitated of the SARS-CoV and the SARS-CoV-2 into the human cells [57].
Infection and challenge of SARS-CoV with recombinant SARS-Spike protein significantly reduces ACE-2expression in the lungs and in the cell culture and led to more severe lung damage [58]. Reduction of viral ACE-2 emerges to be very important in mediating lung damage [58, 59]. We postulate that overexpression of ACE-2 in patients who are chronically exposed to the high concentration of PM2.5 can facilitate the viral penetration, resulting in a decrease in ACE-2 leading to more intense forms of the disorder. This may explain the low incidence of severe pneumonia in the children, most of whom are asymptomatic. Limitations in PM2.5 exposure owing to young age in children may excuse them from overexpression of the ACE-2 receptor. Out of all infected patients in China, less than 1% were under 10 years old children [60] that developed milder disease [61]. Therefore, chronic upregulation of the ACE-2 in the PM 2.5 dose-dependent manner can explain a wide variety of clinical manifestations from asymptomatic patients to patients with severe, moderate, or mild diseases [61]. According to findings, the average viral load is 60 times higher in the SARS-CoV2 severe cases than in the mild cases [62].
While the Covid-19 causes only mild symptoms in most patients, in rare cases it can lead to an extreme-inflammatory response leading to ARDS and death.
In addition to the clear overlap between the Covid-19-induced ARDS symptoms and prolonged air pollution exposure, there is evidence of an association between Covid-19 cases and ozone and nitrogen oxide concentrations[15]. Another study in northern Italy found that air pollutant concentrations may play a role in increasing Covid-19 mortality in that region [16]. Similar evidence in Italy suggests that PM may actually carry the virus and thus directly contribute to its spread [63]. In the Netherlands also, preliminary analysis evidenced a link between the PM2.5 concentrations and Covid-19 cases [64]. Results of the study of the relationship between the Covid-19 mortality rate and long-term exposure to the high concentration of PM2.5 in US cities show that an increase of 1μg / m3 in PM2.5 concentration was associated with the 8% increase in the death rate of Covid-19 [18].
Air pollution exposure and neurological complications of COVID-19
A body of evidence that supports the involvement of CNS in path physiology of the COVID-19 is increasing. Though COVID-19 mainly affects the respiratory and cardiovascular systems, the recent reports suggest that it can cause certain neurological symptoms including hypoglycemia, dizziness, headache, encephalitis, encephalopathy, acute cerebrovascular events, a disorder of consciousness, skeletal muscle injury, and poly Neuritis that can the even precede common features such as cough and fever [65]. Furthermore, the recovered COVID-19 patients without specific neurological manifestations during the acute stage also showed brain damages even three months after discharge [66]. Mechanically, have been proposed several pathways in which SARS-CoV-2 led to neurological complications such as direct damage to specific receptors and neurons, secondary hypoxia, cytokine-related damage, and reversal travel along fibers of the nerve [67]. In any case, the exact mechanisms of COVID-19 neurological manifestations are largely unattainable. Generally, neurological dysfunction can be a result of systemic disease, direct viral injury, and /or systemic inflammation [68]. The virus can interact with the brainstem pathways, thus in addition to direct lung damage, leading to indirect respiratory dysfunction. The coronavirus uses the ACE2 receptor to enter cells and circulate. Because also these receptors are found in the brain glial cells and the spinal neurons, they can attach to, multiply and damage the neuronal tissue [65].
Some studies indicate that the SARS-CoV-2, which resembles the UFPs, can reach a brain through an olfactory nerve and OB [30, 69]. Viral binding to BBB endothelial cells through ACE2 expression further disrupts the BBB and facilitates viral entry into CNS. Pulmonary viral invasion causes systemic inflammation (through increased levels of IL-6, IL-12, IL-15, and TNFα), leading to a CNS pro-inflammatory state through glial cell activation [30, 67]. Local and systemic effects of the lung alveolar together cause severe hypoxia and ultimately lead to cerebrovascular dysfunction [67]. Recently, the examining relationship between coronavirus mortality and prolonged NO2 exposure showed that air pollution exposure may be a major contributor to COVID-19-related mortality [15, 22].
The SARS-CoV-2 known pathophysiology and other Coronaviruses provide clues as to the possible mechanisms of CNS damage. Now it has been shown that SARS-CoV-2, like other human Coronaviruses (HCoV) of which the SARS-CoV-2 virus group is a member, can attack the CNS. The SARS-CoV-2 attack is thought to require both cell surface receptors to viral spike protein binding and S protein priming by cell proteases. In particular, SARS-CoV-2 uses ACE2 as the input receptor and the cell protease of TMPRSS2 for the S protein primer [70]. Cross surveys on ACE2 and the TMPRSS2-positive cells on human tissue found these proteins the expression in the nasal goblet and the ciliated epithelial cells and also oligodendrocytes [71]. Co-expression of ACE2/TMPRSS2 in oligodendrocytes can be one method of CNS proliferation or infiltration. During the SARS-CoV pandemic, encephalitis acute cases were reported with the virus detected in the patient CSF [72, 73]. Some pathological studies reported that infectious virus and viral RNA were identified in the brain tissue. In post-mortem four SARS-CoV patients examination and four individuals control, found SARS-CoV RNA and antigen in the cerebellum of people infected with SARS-CoV [74]. Other Coronaviruses have already been found in autopsy studies in the brain:
OC43 and HCoV 229E strains were identified in 44 of the 90 brain donors determined by RT-PCR [75]. OC43 prevalence in patients with multiple sclerosis (MS) was significantly higher than in the control group. Besides, another study showed MCP-1 chemokine mRNA increase in the astrocyte cell lines due to infection of HCoV-OC43[77]. Therefore, these results indicate that HCV infection can exacerbate the neuropathology of MS, raising the possibility that the coronavirus infection can interact with preexisting neuropathology or coexist, leading to neurological or chronic complications create. Coronaviruses can invade the CNS through a transneuronal or hematopoietic pathway. The early SARS-CoV-2neuroinvasion may be via the OB [78]. Air pollution nanoparticles transport from nasal epithelium to olfactory nerve and then hippocampus (HI) has been shown in mice models [29, 30]. HCoV transport also from nasal epithelium to olfactory nerve and then CNS has been shown in rat models. Only three days after HCoV-OC4 intranasal inoculation, the transgenic mice had cells containing specific viral antigens in OB. During the seven days post inoculation, at the same time as fatal clinical encephalitis, the virus spread throughout the whole brain. In mice, like HCoV-OC43, following experimental nasal inoculation, SARS-CoV has been found in CNS. Within over 1-2 weeks after infection, and approximately eight-fold increase in density of SARS-CoV-positive cells was observed in the CNS, mainly accumulated in the HI [78]. Clinically SARS-CoV is associated with encephalitis cases, viral particles, and ischemic changes in the neurons and genome sequencing has been detected in human autopsy in the brain [79].
Although the genomic identities of SARS-CoV and SARS-CoV-2 are up to 82% similar, SARS-CoV-2 have unique genetic traits, particularly encoding proteins that can contribute to both virus replication and pathogenicity [80]. The significance and implications of genetic differences are still unclear. Coronaviruses may be cross into CNS through the BBB that is compromised by inflammatory mediators, endotheliitis or endothelins injury, transmigration of virus-carrying macrophages, or direct endothelial cells infection themselves [71, 75, 81].
SARS-CoV, the SARS responsible virus, after deployment in the CNS, has been shown that to be rapidly capable of the transneuronal proliferation and infected neurons death in models of transgenic mice that express human ACE2 receptors [82]. Some of the infected mice with HCoV-OC43, the human coronavirus causing the common cold, develop a neurological infection and acute encephalitis or may survive the acute infection and behavioral changes of developing chronic encephalitis and OC43 virus persistence indicate that neurons were affected [83]. Infection of cortical neurons and hippocampal by HCOV-OC43 in the tissue culture have shown that the death of cells may occur due to apoptosis of the infected, neighboring and non-infected cells [83]. Previous findings have shown that TNF-⍺, a known stimulant for apoptosis, is released by the infected cells and can be involved in uninfected cells apoptosis and in microglia infiltration and activation [84]. Both SARS-CoV-2 and the SARS-CoV enter the host cells via ACE2 receptors, but the phylogenetic data and complex receptor analysis at the atomic level suggest that coronavirus can recognize the human ACE2 with greater efficiency [85, 86].
In one study that introduced soluble human SARS-CoV-2 and ACE2 (hrsACE2) at the clinical-grade in the engineered human tissue, the hrsACE2 was capable of effectively inhibiting the virus and preventing it from attaching to cells [87]. ACE2, which is high levels expressed in the various tissues including brain endothelial cells, type 2 alveolar cells, glial cells, and neurons [88-90], the renin-angiotensin system regulates by opposing ACE signaling via the production of vasodilator peptide angiotensin [91-93]. Has been shown SARS-CoV to reduce the ACE2 levels in mice lungs without detectable altering in the ACE expression [58]. By reducing ACE2 regulation expression, the SARS-CoV-2 can upset the ACE/ACE2 cerebrovascular control delicate balance, which may lead to excessive vasoconstriction, unopposed ACE signal, or impaired cerebral auto regulation. It has previously been shown that SARS-CoV infection with high levels of cytokines, including TNFα, IL-6, IL12, IL-1β, and INFγ, is a phenomenon known as the "cytokine storm" [91, 94], these pro-inflammatory cytokines high levels are associated with poor outcomes. The SARS-CoV-2 has such pathogenicity because the severity of COVID-19 is now associated with increased levels of TNFα, INFγ, IL-17, IL-10, IL-8, IL-7, IL-6, IL-2, IL-1β, INFγ-inducible protein-10, MCP1, and G-CSF [91, 95, 96]. Elevated IL-6 and ferritin, hyper inflammation markers, have previously been associated with mortality in the COVID-19 [91, 97]. Cytokine storms can contribute to neurotoxicity and acute lung injury; the mice infected with the influenza A virus showed a significant increase in cytokines IL-1β, IL-6, and TNF-α with excessive vascular permeability in the lungs and also brain within the 6 days of the inoculation [98]. The BBB integrity can be disrupted by immune-mediated toxicity and cytokine-induced damage in absence of the direct viral spread and or attack. Findings suggest that ANE, for example, maybe caused by cytokine toxicity [99]. Also, cytokines can be directly neurotoxic, mediating or even inhibiting CNS cell injury either acting alone or synergistically [100]. The methods in which observed highly activated signaling of cytokine in infection of SARS-CoV-2 may affect neuronal outcome via altering neuro-inflammatory pathways are not known [101].
Scientific studies on exposure [102] can help transmit the virus via aerosol, how to use personal protective equipment in personal exposure, source of entry into the receptor pathways, the survival of the virus at different levels, in various environments conditions and meteorological including temperature, ultraviolet radiation, humidity [103, 104]. Extreme heat and or the arrival of the cold season and decreasing air temperature and the occurrence of temperature inversion, especially in crowded cities, can interfere with the dispersion of air pollutants on the ground level and increase the concentration of pollutants and the health damage.
Considering the additional risk that some communities may face withCOVID-19 and the extra burden that they face during severe weather events, also the interplay between COVID-19 prevention measures and coping strategies against the severe reduction of air temperature in cold seasons and or extreme heat (for example, restrictions on service centers and shops, respect for social distance, wearing a mask despite the occurrence of respiratory distress, the occurrence of temperature inversion in winter and increasing concentrations of air pollutants, and traffic restrictions in cities, …), epidemic preparedness strategies are essential for the climate adaptation. In these time-sensitive pandemics, to help inform the targeted interventions and reduce disease prevalence while minimizing socio-economic inequalities and considering the combined risks in the changing environment, especially given recession-predicted economic, practical evidence is needed.
Funding: This review received no external funding and was initiated and funded by Dr. Ehsanifar Research Lab, Tehran, Iran.
Institutional Review Board Statement: Not applicable
Informed Consent Statement: Not applicable
Data Availability Statement: Not applicable
Acknowledgments: We thank Dr. Ehsanifar Lab. Tehran, Iran.
Conflicts of Interest:
The author declare no conflict of interest.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
